Why Is KODIAK SCIENCES INC (KOD) Stock Moving Today?
By the Top Tier Newswire AI Desk · October 2, 2026 at 10:02 AM ET · reviewed against 8 wire stories
KODIAK SCIENCES INC (KOD) is drawing unusual attention today. Our newswire has captured 8 stories on KOD across 5 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
KOD stock is down 4.71% at $93.82 as of the latest trade, following a sharp intraday selloff triggered by mixed developments in the eye disease drug space. The stock opened with a modest 0.5% gap up from the prior close but quickly reversed course after competitive updates from rival companies cast doubt on the market potential for Kodiak Sciences' pipeline. The session low reached $93.00, with volume so far at 0.3 million shares, nearly double the 3-month average.
What Happened
The decline began after Kodiak Sciences and 4D Molecular released clinical trial updates for their respective eye disease treatments. These developments raised concerns about the competitive landscape for wet AMD therapies, a key focus area for Kodiak. The selloff accelerated in the early morning hours as investors digested the data and adjusted their positions. The stock had previously surged more than 191.8% over the last eight sessions, rising from $33.80 to $98.63, but the recent volatility has pushed it to a fresh 52-week low on October 2. Meanwhile, UBS maintained a Buy rating on the stock earlier in the week, raising its price target to $120.
What The Data Shows
Kodiak Sciences opened at $99.00, reached a high of $99.90 at 9:20 AM ET, and then declined to a low of $93.00 at 10:00 AM ET. The stock is trading at $93.94 with 0.3 million shares exchanged so far, which is 0.2 times the 3-month average. Insiders, including Baker Bros. Advisors LP, have made three separate purchases totaling $157.0 million in the last 90 days. The stock has a beta of 2.18, indicating higher volatility than the broader market, and a market cap of $5.9 billion despite unprofitable earnings (TTM EPS -4.18).
What To Watch
Kodiak Sciences is not scheduled to report earnings in the near term. Investors should monitor the breadth of coverage and sentiment shifts as more trial data emerges in the competitive eye disease space.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
KOD · Oct 2 session (5-min) · -3.75% vs prior close · updated 8:58 PM ETAI sentiment, last 36h · averaged over 8 stories · 58/100 bullish
The headlines behind the move
Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
5h agoSeeking AlphaBEARISH 44Analyst
Kodiak Sciences: Sticking With Hold As Optimistic Assumptions Are Already Priced In
Analyst maintains a Hold on Kodiak Sciences stock: its $6.8 billion valuation embeds optimistic Zenkuda sales, and launch spending makes more financing likely.
6h agoGuruFocusBULLISH 63Analyst
KOD Maintained by UBS -- Price Target Raised to $150
12h agoThe FlyBULLISH 67Analyst
Kodiak Sciences price target raised to $150 from $120 at UBS
1d agoGuruFocusBULLISH 67Earnings
Kodiak Sciences (KOD) Reports Q3 EPS Beat, Bolstered by Strong Insider Buying and Solid Cash Position
1d agoSeeking AlphaBULLISH 58Earnings
Kodiak Sciences GAAP EPS of -$1.05 beats by $0.01
Kodiak Sciences press release (KOD): Q3 GAAP EPS of -$1.05 beats by $0.01.Kodiak ended the third quarter of 2026 with $88.7 million of cash and cash...
Kodiak Sciences Inc. (KOD) files 8-K: Items 2.02, 9.01
Filed: 2026-11-12 AccNo: 0001193125-26-458248 Size: 321 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
1d agoPR NewswireBULLISH 58Earnings
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2026 Financial Results
PALO ALTO, Calif., Nov. 12, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2026. "We believe Kodiak stands apart in retina, with three late-stage assets that together give...
Frequently asked questions
Why is KOD stock moving today?
KODIAK SCIENCES INC (KOD) is drawing unusual attention today. Our newswire has captured 8 stories on KOD across 5 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100). The most recent driver: "Kodiak Sciences: Sticking With Hold As Optimistic Assumptions Are Already Priced In" (Seeking Alpha).
Is KOD a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of KOD coverage reads 58/100 over 8 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →